Approval · Notice of Compliance 1846 · 1999
CEREZYME: Notice of Compliance 1846
Issued December 20, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1846
- Date
- December 20, 1999
- Company
- Genzyme CorporationCambridge, Massachusetts, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to the manufacturing facility
- Therapeutic class
- Enzyme replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEREZYME | Not yet assigned | — |
Medicinal ingredients
- IMIGLUCERASE 200 UNIT per VIAL